Education
About Us
Working with TipRanks
Follow Us
Percy H. Carter Insider Profile
4 Followers
Percy H. Carter, CSO at Blueprint Medicines, holds 0.00 shares in Blueprint Medicines (Ticker: BPMC).
Profitable Transactions
2 out of 9 Profitable Transactions
Average Return
-29.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Percy H. Carter does not currently own shares as a corporate insider.
A breakdown of Percy H. Carter's holdings
Insider Roles
Percy H. Carter does not currently hold a role as a corporate insider.
Roles that Percy H. Carter holds in companies
Most Profitable Insider Trade
Stock:
Blueprint Medicines
(BPMC)
(BPMC)
Rating:Informative Sell
Date:Jun 08, 2022 - Jun 08, 2023
Return:+12.20%
The most profitable trade made by Percy H. Carter
Percy H. Carter's Trading History
List of latest transactions for each holding click on a transaction to see Percy H. Carter's performance on stock
You May Also Like
Percy H. Carter insider profile FAQ
What is the percentage of profitable transactions made by Percy H. Carter?
The percentage of profitable transactions made by Percy H. Carter is 22%.
What is the average return per transaction made by Percy H. Carter?
The average return per transaction made by Percy H. Carter is -29.20%.
What stocks does Percy H. Carter hold?
Percy H. Carter holds: BPMC stocks.
What was Percy H. Carter’s latest transaction?
Percy H. Carter latest transaction was an Uninformative Buy of ―.
What was Percy H. Carter's most profitable transaction?
Percy H. Carter’s most profitable transaction was an Informative Sell of BPMC stock on June 8, 2022. The return on the trade was 12.20%.
What is Percy H. Carter's role in Blueprint Medicines?
Percy H. Carter's role in Blueprint Medicines is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.